Who owns CHEMOMAB THERAPEUTICS LTD?
- Ticker: CMMB
- CUSIP Number: 16385c104
Tip: Access positions for across all investors
Analyze quarterly positions in Chemomab Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Chemomab Therapeutics stock
Who bought or sold CHEMOMAB THERAPEUTICS LTD this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
OrbiMed Advisors | 2.2M | $1.1M | 0% | Dec 2023 |
|
Ikarian Capital | 213k | $109k | 0% | Dec 2023 |
|
Two Sigma Investments | 56k | $29k | 100% | Dec 2023 |
|
Two Sigma Advisers | 35k | $18k | 100% | Dec 2023 |
|
Citadel Advisors | 33k | $17k | 100% | Dec 2023 |
|
Kestra Private Wealth Services | 31k | $16k | 0% | Dec 2023 |
|
Virtu Financial | 26k | $13k | 100% | Dec 2023 |
|
Millennium Management | 20k | $10k | 100% | Dec 2023 |
|
Rhumbline Advisers | 19k | $9.5k | 555% | Dec 2023 |
|
Advisor Group Holdings | 585.00 | $297.004500 | -67% | Dec 2023 |
|
Moser Wealth Advisors | 500.00 | $255.000000 | 0% | Dec 2023 |
|
Who sold out of Chemomab Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Newbridge Financial Services Group | Sep 2023 | 1.1k | $985.050000 |